Babar Bashir
Impact in
- Oncology top 2%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Oncology 30
- COVID-19 and healthcare impacts 11
- Cancer Immunotherapy and Biomarkers 8
- Pancreatic and Hepatic Oncology Research 6
- CAR-T cell therapy research 2
-
- Immunotherapy and Immune Responses 6
- Phagocytosis and Immune Regulation 2
- Co-authors
- Adam Eugene Snook (9 shared papers)Walter K. Kraft (3 shared papers)Inna Chervoneva (1 shared paper)Douglas F. Stickle (1 shared paper)Scott Arthur Waldman (5 shared papers)Melissa Ann Wilson (1 shared paper)Jeffrey A. Rappaport (3 shared papers)Vivek Narayan (1 shared paper)
- Journals
- Annals of Oncology (10 papers)Cancer Biology & Therapy (4 papers)JAMA Oncology (3 papers)JAMA Network Open (3 papers)Clinical and Translational Science (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Babar Bashir
61 papers receiving 2.3k citations
Babar Bashir's Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 1.4k
- Infectious Diseases 686
- Obstetrics and Gynecology 79
- Internal Medicine 28
- Neurology 94
Countries citing papers authored by Babar Bashir
This map shows the geographic impact of Babar Bashir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Babar Bashir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Babar Bashir more than expected).
Fields of papers citing papers by Babar Bashir
This network shows the impact of papers produced by Babar Bashir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Babar Bashir. The network helps show where Babar Bashir may publish in the future.
Co-authors
The 25 scholars most cited alongside Babar Bashir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Hit paper breakdown → | 2020 | 1331 |
| 2 | 2021 | 234 | |
| 3 | 2021 | 141 | |
| 4 | 2024 | 62 | |
| 5 | 2022 | 47 | |
| 6 | 2018 | 35 | |
| 7 | 2022 | 31 | |
| 8 | 2021 | 29 | |
| 9 | 2023 | 29 | |
| 10 | 2020 | 28 | |
| 11 | 2024 | 27 | |
| 12 | 2020 | 26 | |
| 13 | 2024 | 26 | |
| 14 | 2019 | 21 | |
| 15 | 2016 | 19 | |
| 16 | 2019 | 19 | |
| 17 | 2022 | 17 | |
| 18 | 2017 | 14 | |
| 19 | 2021 | 14 | |
| 20 | 2021 | 14 |
About Babar Bashir
Babar Bashir is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Cancer Research and Hepatology, having authored 62 papers that have together received 2.4k indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (11 papers), Cancer Immunotherapy and Biomarkers (8 papers), Pancreatic and Hepatic Oncology Research (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer Genomics and Diagnostics (4 papers), Phagocytosis and Immune Regulation (2 papers), CAR-T cell therapy research (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Oncology (1.4k citations), Infectious Diseases (686 citations), Obstetrics and Gynecology (79 citations), Internal Medicine (28 citations) and Neurology (94 citations). Babar Bashir has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Adam Eugene Snook, Walter K. Kraft, Inna Chervoneva, Douglas F. Stickle, Scott Arthur Waldman, Melissa Ann Wilson, Jeffrey A. Rappaport, Vivek Narayan, William Kevin Kelly and John C. Flickinger. Their work appears in journals such as Annals of Oncology, Cancer Biology & Therapy, JAMA Oncology, JAMA Network Open and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.